BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35821240)

  • 1. The CD226/TIGIT axis is involved in T cell hypo-responsiveness appearance in long-term kidney transplant recipients.
    Del Bello A; Gouin A; Chaubet C; Kamar N; Treiner E
    Sci Rep; 2022 Jul; 12(1):11821. PubMed ID: 35821240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8
    Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
    Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.
    Deng C; Chen Y; Li W; Peng L; Luo X; Peng Y; Zhao L; Wu Q; Zhang W; Zhang X; Fei Y
    J Autoimmun; 2020 Sep; 113():102485. PubMed ID: 32466852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis.
    Li W; Deng C; Yang H; Lu X; Li S; Liu X; Chen F; Chen L; Shu X; Zhang L; Liu Q; Wang G; Peng Q
    Arthritis Res Ther; 2021 Jan; 23(1):15. PubMed ID: 33413573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TIGIT/CD226 axis regulates human T cell function.
    Lozano E; Dominguez-Villar M; Kuchroo V; Hafler DA
    J Immunol; 2012 Apr; 188(8):3869-75. PubMed ID: 22427644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in CD226 expression on CD4
    Li C; Zhou J; Shao J; Yuan L; Cheng Q; Wang L; Duan Z
    Biosci Trends; 2023 May; 17(2):168-171. PubMed ID: 37081668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD4
    Šunina M; Alnek K; Kisand K; Uibo R
    Scand J Immunol; 2021 Sep; 94(3):e13089. PubMed ID: 35971920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD226 opposes TIGIT to disrupt Tregs in melanoma.
    Fourcade J; Sun Z; Chauvin JM; Ka M; Davar D; Pagliano O; Wang H; Saada S; Menna C; Amin R; Sander C; Kirkwood JM; Korman AJ; Zarour HM
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE.
    Wang N; Liang S; Jin J; Fang L; Ma Q; Wang X; Song Y; Chen L
    Immunol Res; 2019 Dec; 67(6):486-496. PubMed ID: 31919790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Senescence Marker TIGIT Identifies Polyfunctional Donor-Reactive CD4+ T Cells Preferentially Lost After Kidney Transplantation.
    van der List ACJ; Litjens NHR; Klepper M; Betjes MGH
    Front Immunol; 2021; 12():656846. PubMed ID: 33995373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perturbed CD8
    Tauriainen J; Scharf L; Frederiksen J; Naji A; Ljunggren HG; Sönnerborg A; Lund O; Reyes-Terán G; Hecht FM; Deeks SG; Betts MR; Buggert M; Karlsson AC
    Sci Rep; 2017 Jan; 7():40354. PubMed ID: 28084312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226.
    Fuhrman CA; Yeh WI; Seay HR; Saikumar Lakshmi P; Chopra G; Zhang L; Perry DJ; McClymont SA; Yadav M; Lopez MC; Baker HV; Zhang Y; Li Y; Whitley M; von Schack D; Atkinson MA; Bluestone JA; Brusko TM
    J Immunol; 2015 Jul; 195(1):145-55. PubMed ID: 25994968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive binding of CD226/TIGIT with poliovirus receptor regulates macrophage polarization and is involved in vascularized skin graft rejection.
    Zhang D; Liu Y; Ma J; Xu Z; Duan C; Wang Y; Li X; Han J; Zhuang R
    Am J Transplant; 2023 Jul; 23(7):920-934. PubMed ID: 37054890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD226 and TIGIT Cooperate in the Differentiation and Maturation of Human Tfh Cells.
    Yasutomi M; Christiaansen AF; Imai N; Martin-Orozco N; Forst CV; Chen G; Ueno H
    Front Immunol; 2022; 13():840457. PubMed ID: 35273617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD226
    Jin HS; Ko M; Choi DS; Kim JH; Lee DH; Kang SH; Kim I; Lee HJ; Choi EK; Kim KP; Yoo C; Park Y
    Cancer Immunol Res; 2020 Jul; 8(7):912-925. PubMed ID: 32265229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher TIGIT
    Jin Z; Lan T; Zhao Y; Du J; Chen J; Lai J; Xu L; Chen S; Zhong X; Wu X; Li Y
    Immunol Invest; 2022 Jan; 51(1):40-50. PubMed ID: 32819181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ratio of CD226 and TIGIT Expression in Tfh and PD-1
    Fan JW; Fan Y; Wan ZL; Yan L; Li YM; Bai YJ; Wang LL; Chen J; Li Y
    J Immunol Res; 2022; 2022():5326083. PubMed ID: 35733922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis.
    Deng C; Li W; Fei Y; Wang L; Chen Y; Zeng X; Zhang F; Li Y
    Front Immunol; 2020; 11():1619. PubMed ID: 32793241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8
    Banta KL; Xu X; Chitre AS; Au-Yeung A; Takahashi C; O'Gorman WE; Wu TD; Mittman S; Cubas R; Comps-Agrar L; Fulzele A; Bennett EJ; Grogan JL; Hui E; Chiang EY; Mellman I
    Immunity; 2022 Mar; 55(3):512-526.e9. PubMed ID: 35263569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.
    Chauvin JM; Ka M; Pagliano O; Menna C; Ding Q; DeBlasio R; Sanders C; Hou J; Li XY; Ferrone S; Davar D; Kirkwood JM; Johnston RJ; Korman AJ; Smyth MJ; Zarour HM
    Clin Cancer Res; 2020 Oct; 26(20):5520-5533. PubMed ID: 32591463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.